Skip to main content
Clinical Trials/CTRI/2026/04/107365
CTRI/2026/04/107365Not yet recruitingUnknown

A Prospective single arm clinical study to assess the clinical outcomes and patient satisfaction of a pre-loaded Swiss Phob Toric Hydrophobic intraocular lens in patients undergoing bilateral cataract surgery.

Prof D Lional Raj1 site in 1 country30 target enrollmentStarted: April 21, 2026Last updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1

Study Overview

Brief Summary

The objectives of this study are to evaluate the binocular visual acuity for far, intermediate and near distance, and to measure the Defocus Curve, Contrast Sensitivity & patient satisfaction among patients undergoing binocular cataract with Advanced Monofocal Aspheric intraocular lens implantation.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Cataractous lens changes as demonstrated by best corrected visual acuity of 20/40 or worse either with or without a glare source present (e.g., Brightness Acuity Tester) or with significant cataract-related visual symptoms;
  • Best corrected visual acuity to be better than 20/30 after cataract removal and IOL implantation as estimated by potential acuity meter (PAM) or surgeon estimation Have corneal thickness more than600 µm by OCT
  • Less than or equal to 1.0 D of preoperative keratometric astigmatism
  • Clear intraocular media other than cataract
  • Given written informed consent by subject.
  • Subjects are willing and able to comply with schedule for follow up visits
  • Subjects should be 22 years or older.

Exclusion Criteria

  • Systemic disease that could increase the operative risk or confound the outcome;
  • Systemic medications that may confound the outcome or increase the risk to the subject in the opinion of the investigator [tamsulosin hydrochloride (Flomax) or other medications with similar side effects (floppy iris syndrome)];
  • Ocular condition that may predispose for future complications
  • Previous intraocular or corneal surgery that might confound the outcome of the investigation or increase the risk to the subject
  • Pregnant, lactating during the course of the investigation, or has another condition with associated fluctuation of hormones that could lead to refractive changes;
  • Subjects with diagnosed degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that are predicted to cause future acuity loss to 20/30 or worse
  • If preclinical testing or risk analysis indicates potential for substantially increased light scatter over a monofocal lens, then exclude subjects who are expected to require retinal laser treatment.

Investigators

Sponsor
Prof D Lional Raj
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Lional Raj D

Dr. Agarwals Eye Hospital

Study Sites (1)

Loading locations...

Similar Trials